Filed: 2/12/2025ACC: 0001766721-25-000001
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $281.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$281.83M
Total AUM (reported)
20.09M
Total Shares
Allocation by class
COM$216.01M76.6%
SPONSORED ADS$55.44M19.7%
COM CL A$7.52M2.7%
COM NEW$2.86M1.0%
Portfolio Concentration
Top 3$231.86M82.3%
4–10$45.49M16.1%
11–25$4.49M1.6%
Top 3 weight
82.3%
Top 10 weight
98.4%
Voting Authority Distribution
Total shares with voting rights: 20.09M
Sole
Full voting authority
20.09M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$166.51M
59.08%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$51.80M
18.38%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$13.55M
4.81%
Sole
1.02M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$10.22M
3.63%
Sole
1.47M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$10.02M
3.55%
Sole
1.04M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$9.91M
3.52%
Sole
568.92K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$6.76M
2.40%
Sole
2.54M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$3.65M
1.29%
Sole
964.50K
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$3.10M
1.10%
Sole
798.76K
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$1.84M
0.65%
Sole
521.11K
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$1.59M
0.56%
Sole
2.83M
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$1.08M
0.38%
Sole
434.45K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares325.37K
TypeSH
Market value$1.01M
0.36%
Sole
325.37K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc. (OKUR)
SOLEShares88.61K
TypeSH
Market value$762.0K
0.27%
Sole
88.61K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$46.2K
0.02%
Sole
288.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $166.51M 59.08% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $51.80M 18.38% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $13.55M 4.81% | 1.02M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $10.22M 3.63% | 1.47M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $10.02M 3.55% | 1.04M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $9.91M 3.52% | 568.92K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $6.76M 2.40% | 2.54M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $3.65M 1.29% | 964.50K | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $3.10M 1.10% | 798.76K | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $1.84M 0.65% | 521.11K | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $1.59M 0.56% | 2.83M | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $1.08M 0.38% | 434.45K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 325.37K | SH | $1.01M 0.36% | 325.37K | 0.00 | 0.00 |
OnKure Therapeutics, Inc. (OKUR)SOLE | COM CL A | 88.61K | SH | $762.0K 0.27% | 88.61K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $46.2K 0.02% | 288.57K | 0.00 | 0.00 |